| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |